Herpetic ocular disease: therapy of persistent epithelial defects.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000494:pharmacology / Q000627:therapeutic use; D000956:Antigens, Viral; D002455:Cell Division / Q000187:drug effects; D004195:Disease Models, Animal; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007634:Keratitis / Q000188:drug therapy / Q000382:microbiology; D007635:Keratitis, Dendritic / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D010277:Parasympathomimetics / Q000494:pharmacology; D013997:Time Factors; D014605:Uveitis / Q000188:drug therapy / Q000382:microbiology; D014740:Vidarabine / Q000627:therapeutic use; D014945:Wound Healing / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000891:Anti-Infective Agents, Local; D000956:Antigens, Viral; D010277:Parasympathomimetics; D014740:Vidarabine; D007065:Idoxuridine